United Capital Financial Advisors’s VanEck Pharmaceutical ETF PPH Stock Holding History

United Capital Financial Advisors’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-101,768	Closed	-$7.2M	–	1298
2015 Q2	$7.2M	Buy	101,768 +29,747	+41%	+$2.14M	0.08%	276
2015 Q1	$5.09M	Buy	72,021 +18,692	+35%	+$1.27M	0.06%	329
2014 Q4	$3.43M	Sell	53,329 -8,266	-13%	-$527K	0.05%	343
2014 Q3	$3.92M	Buy	61,595 +48,780	+381%	+$3.02M	0.07%	292
2014 Q2	$795K	Buy	+12,815	New	+$762K	0.01%	601

Other funds holding PPH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

MIM

Macroview Investment Management Bethesda, Maryland $144M AUM 19.29% 1-Year Est. Return

AHS

Aspiriant Holdings S3 Los Angeles, California $233M AUM 3.13% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

United Capital Financial Advisors's PPH Position: Q3 2015 in Review

United Capital Financial Advisors sold out of VanEck Pharmaceutical ETF (PPH) in Q3 2015, closing a stake of 101,768 shares — an estimated $7.2M sold.

United Capital Financial Advisors first reported a position in PPH in Q2 2014 and held it in 5 quarters. The position peaked at $7.2M in Q2 2015. 60 funds tracked by Wall St. Rank hold PPH as of Q3 2015.

United Capital Financial Advisors reported no remaining VanEck Pharmaceutical ETF position as of Q3 2015 after selling out during the quarter.
United Capital Financial Advisors sold 101,768 VanEck Pharmaceutical ETF shares in Q3 2015, an estimated $7.2M.
United Capital Financial Advisors first reported a position in VanEck Pharmaceutical ETF in Q2 2014 and held it in 5 quarters.
United Capital Financial Advisors's VanEck Pharmaceutical ETF position peaked at $7.2M in Q2 2015.
60 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q3 2015.

Based on United Capital Financial Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.